Effects of Prenatal Drug Exposure on Neurobehavioral Functioning in Young Infants

References

• Chasnoff I J, Bussey M E, Savich R, Stack C M. Perinatal cerebral infarction and maternal cocaine use. J Pedialr. 1986; 108: 456–459
   Google Scholar
• Frank D A, Zuckerman B S, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988; 82(6)888–895
   PubMed Web of Science ®Google Scholar
• Gillogley K M, Evans A T, Hansen R L. The perinatal impact of cocaine, amphetamine and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol. 1990; 163: 1535–1542
   PubMed Web of Science ®Google Scholar
• McCalla S, Minkoff H L, Feldman J, et al. The biologic and social consequences of perinatal cocaine use in an inner-city population. Am J Obstet Gynecol. 1991; 164: 625–630
   PubMed Web of Science ®Google Scholar
• Neerhoff M G, MacGregor S N, Retzky S S, Sullivan T P. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome. Am J Obstet Gynecol. 1989; 161: 633–638
   PubMed Web of Science ®Google Scholar
• Ostrea E M, Brady M J, Gause S, Raymundo A L, Stevens M. Drug screening of newborns by meconium analysis: a large scale, prospective, epidemiologic study. Pediatrics. 1992; 89: 107–113
   PubMed Web of Science ®Google Scholar
• Wang L H, Rudolph A M, Bevet L Z. Pharmacokinetics of drugs and metabolites in the maternal-placental-fetal unit. Prenatal Drug Exposure: Kinetics and Dynamics, C N Chiang, C N Lee. U.S. Dept of Health and Human Services, Rockville, MD 1980; 25–38
   Google Scholar
• Gawin F H, Ellinwood E H. Cocaine and other stimulants: actions, abuse and treatment. NEnglJ Med. 1988; 318: 1173–1182
   PubMed Web of Science ®Google Scholar
• Wise R A. Neural mechanisms of the reinforcing action of cocaine. Cocaine in the Brain, N D Volkow, A C Swann. Rutgers University Press, LondonUK 1990; 42–57
   Google Scholar
• Jacobs B L. Overview of the activity of the brain monoaminergic neurons across the sleep-wake cycle. Sleep Neurotransmitters and Neuromodulators, A Wauquier, J M Monti, J M Gaillard, M Radilovich. Raven Press, New York, NY 1985; 1–14
   Google Scholar
• Volpe J J. Effect of cocaine use on the fetus. NEnglJ Med. 1992; 327(6)399–407
   PubMed Web of Science ®Google Scholar
• Lauder J M. Neurotransmitters as morphogens. Prog Brain Res. 1988; 74: 365
   Google Scholar
• Miller J C, Friedhoff A J. Prenatal neurotransmitter programming of postnatal receptor function. Prog Brain Res. 1988; 73: 509
   Google Scholar
• Mirochnick M, Meyer J, Frank D A, et al. Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana. Pediatrics. 1997; 99: 555–559
   Google Scholar
• Needlman R, Zuckerman B S, Anderson G, et al. Cerebrospinal fluid mono-amine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study. Pediatrics. 1993; 92(1)55–60
   Google Scholar
• Chasnoff I J, Griffith D R, Freier C, Murray J. Cocaine/polydrug use in pregnancy: two-year follow-up. Pediatrics. 1989; 89(2)284–289
   Google Scholar
• Coles C D, Platzman K A, Smith I, James M E, Falek A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxi-col Teratol. 1992; 14: 23–33
   PubMed Web of Science ®Google Scholar
• Delaney-Black V, Covington C, Ostrea E, et al. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics. 1996; 98: 735–740
   PubMed Web of Science ®Google Scholar
• Tronick E Z, Frank D A, Cabral H, Mirochnick M, Zuckerman B S. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics. 1996; 98: 76–83
   PubMed Web of Science ®Google Scholar
• Eisen L N, Field T F, Bandstra S E, et al. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics. 1991; 88: 477–480
   PubMed Web of Science ®Google Scholar
• Mayes L C, Granger R H, Frank M A, Bornstein M, Schottenfield R. Neurobehavioral profiles of infants exposed to cocaine prenatally. Pediatrics. 1993; 91: 778–783
   PubMed Web of Science ®Google Scholar
• Neuspiel D R, Hamel S C, Hochberg E, Greene J, Campbell D. Maternal cocaine use and infant behavior. Neurotoxicol Teratol. 1991; 13: 229–233
   PubMed Web of Science ®Google Scholar
• Beeghly M, Brazelton T B. Discriminant validity of the Behavioral Qualifier Scoring System (QSS-T). Pediatr Res. 1994; 35(4)18A
   Google Scholar
• Behnke M, Eyler F D, Kazimour K. Developmental outcome of children of foster care who were cocaine-exposed in utero. Pediatr Res. 1991; 29(4)251A
   Google Scholar
• Hurt H. Malmud E, Brodsky N, Gianetta J. Prenatal exposure to cocaine has no effect on infant performance on Bayley Scales of Infant Development. Pediatr Res. 1992; 31(4)251A
   Google Scholar
• Kaiser K M, Mooney K M, Anday E K. Effects of in-utero cocaine exposure on early infant development. Pediatr Res. 1992; 31(4)251A
   Google Scholar
• Billman D O, Nemeth P B, Heimler R, Sasidharan P. Prenatal cocaine/polydrug exposure: effect of race on outcome. J Perinatal. 1996; 16: 366–369
   Google Scholar
• Singer L, Arendt R, Yamashita T, Minnes S, Parkas K, Kliegman R. Development of infants exposed in utero to cocaine. Pediatr Res. 1992; 31(4)260A
   Google Scholar
• Rodning C, Beckwith L, Howard J. Characteristics of attachment organization and play organization in prenatally drug-exposed toddlers. Dev Psychopathol. 1989; 1: 277–289
   Google Scholar
• Howard J, Beckwith L, Rodning C, Kropenske V. The development of young children of substance-abusing parents: insights from seven years of intervention and research. Zero to Three Bulletin. 1989; 9(5)8–12
   Google Scholar
• Struthers J M, Hansen R L. Visual recognition memory in drug-exposed infants. Dev Behav Pediatr. 1992; 13: 108–111
   Web of Science ®Google Scholar
• Alessandri S M, Sullivan M W, Imaizumi S, Lewis M. Learning and emotional responsivity in cocaine-exposed infants. Dev Psychol. 1993; 29: 989–997
   Web of Science ®Google Scholar
• Mayes L C, Bornstein M H, Chawarska K, Haynes O M. Impaired regulation of arousal in 3-month-old infants exposed prenatally to cocaine and other drugs. Dev Psychopathol. 1996; 8: 29–42
   Google Scholar
• Mayes L C, Bornstein M H, Chawarska K, Granger R H. Information processing and developmental assessments in 3-month old infants exposed prenatally to cocaine. Pediatrics. 1995; 95(4)539–545
   PubMed Web of Science ®Google Scholar
• Fetters L, Tronick E Z. Neuromotor development of cocaine exposed and control infants from birth to 15 months: poor and poorer performance. Pediatrics. 1996; 98(5)938–943
   Google Scholar
• Piper M C, Darrah J. Motor Assessment of the Developing Infant. W. B. Saunders, Philadelphia, PA 1992
   Google Scholar
• Chandler L S, Andrews M S, Swanson M W. Movement Assessment of Infants. MAI, Rolling Bay, WA 1980
   Google Scholar
• Brazelton T B. Neonatal Behavioral Assessment Scale. Spastics International Medical Publications, LondonUK 1984
   Google Scholar
• Portney L G, Watkins M R. Foundations of Clinical Research: Applications to Practice. Appleton & Lange, Norwalk, CT 1993
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates, Hillsdale, NJ 1988
   Google Scholar
• Chasnoff I J, Landress H J, Barrett M E. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County Florida. NEnglJMed. 1990; 322: 1202–1206
   PubMed Web of Science ®Google Scholar
• Frank D A, Bresnahan K, Zuckerman B S. Maternal cocaine use: impact on child health and development. Adv Pediatr. 1993; 40: 65–99
   PubMedGoogle Scholar
• Sameroff A J, Chandler M I. Reproductive risk and the continuum of caretaking casualty. Review of Child Development Research, F D Horowitz, M Hetherington, S Scarr-Salapatek, G Siegels. University of Chicago Press, Chicago, IL 1975; 187–224
   Google Scholar
• Sameroff A J, Seifer R, Burocas R, Zax M, Greenspan S. IQ scores of 4 year old children: social and emotional risk factors. Pediatrics. 1987; 79: 343–350
   PubMed Web of Science ®Google Scholar
• Beeghly M, Tronick E Z. Effects of prenatal exposure to cocaine in early infancy: toxic effects on the process of mutual regulation. Inf Mental Health J. 1994; 15: 158–175
   Web of Science ®Google Scholar
• Mayes L C, Bornstein M H. The development of children exposed to cocaine. Developmental Psychopatholo-gy: Perspectives on Adjustment, Risk and Disorder, S S Luthar, D Burack, D Cicchetti, J R Weisz. Cambridge University Press, New York, NY 1997; 166–188
   Google Scholar
• Howard J, Beckwith L, Espinosa M, Tyler R. Development of infants born to cocaine- abusing women: biologic/maternal influences. Neurotoxicol Teratol. 1995; 17: 403–411
   PubMedGoogle Scholar
• Hofkosh D, Pringle J L, Wald H P, Switala J, Hinderliter S A, Hamel S C. Early interactions between drug-involved mothers and infants: within-group differences. Arch Pediatr Adol Med. 1995; 149: 665–672
   PubMedGoogle Scholar
• Frank D A, Rose-Jacobs R, Beeghly M, Augustyn M, Bellinger D, Heeren T, Cabral H, Zuckerman B. Interaction of dose of prenatal cocaine and early intervention on Bayley Scales of Infant Development scores. To be presented at the Annual Meetings of the Ambulatory Pediatric Association, New Orleans, LA, May, 1998
   Google Scholar